Close Menu

NEW YORK (GenomeWeb) – German diagnostics firm Centogene said today that it has entered into an agreement with Denali Therapeutics to conduct a targeted global patient identification and recruitment campaign for the company's Parkinson's disease LRRK2 inhibitor program.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

US National Institutes of Health Director Francis Collins says he will avoid male-only speaker panels.

Two patients fell ill, and one subsequently died, following a fecal microbiome transplant that harbored multi-drug-resistant bacteria, according to the New York Times.

Technology Review reports that eGenesis is testing whether organs from genetically modified pigs can be transplanted into monkeys.

In Science this week: almond reference genome, and more.